Cargando…

High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure

The lifetime risk of developing heart failure is approximately 20%, and survival rates remain poor. Myocardial mitochondrial function has been suggested to play a pivotal role in heart failure pathophysiology. Human studies on ex vivo mitochondrial function have mostly been limited to atrial tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheiber, Daniel, Jelenik, Tomas, Zweck, Elric, Horn, Patrick, Schultheiss, Heinz-Peter, Lassner, Dirk, Boeken, Udo, Saeed, Diyar, Kelm, Malte, Roden, Michael, Westenfeld, Ralf, Szendroedi, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376010/
https://www.ncbi.nlm.nih.gov/pubmed/30765687
http://dx.doi.org/10.1038/s12276-019-0214-6
_version_ 1783395474545311744
author Scheiber, Daniel
Jelenik, Tomas
Zweck, Elric
Horn, Patrick
Schultheiss, Heinz-Peter
Lassner, Dirk
Boeken, Udo
Saeed, Diyar
Kelm, Malte
Roden, Michael
Westenfeld, Ralf
Szendroedi, Julia
author_facet Scheiber, Daniel
Jelenik, Tomas
Zweck, Elric
Horn, Patrick
Schultheiss, Heinz-Peter
Lassner, Dirk
Boeken, Udo
Saeed, Diyar
Kelm, Malte
Roden, Michael
Westenfeld, Ralf
Szendroedi, Julia
author_sort Scheiber, Daniel
collection PubMed
description The lifetime risk of developing heart failure is approximately 20%, and survival rates remain poor. Myocardial mitochondrial function has been suggested to play a pivotal role in heart failure pathophysiology. Human studies on ex vivo mitochondrial function have mostly been limited to atrial tissue obtained during open heart surgery and have provided contradictory results. This study aimed at measuring myocardial mitochondrial function in transcatheter ventricular endomyocardial biopsies and assessing the relationship between oxidative capacity and heart function. We enrolled 40 heart failure patients undergoing ventricular assist device surgery or heart transplantation (34 males, age 57 ± 11 years, body mass index 26.6 ± 4.8 kg/m(2)) and 29 heart transplant recipients of comparable age and body mass index with normal left ventricular function undergoing surveillance biopsies (23 males, 57 ± 12 years, body mass index 26.2 ± 4.1 kg/m(2)). High-resolution respirometry was established in the myocardium to measure oxidative capacity ex vivo. The mitochondrial oxidative capacity was 90% higher in ventricular compared to atrial tissues (n = 11, p < 0.01) of explanted hearts. Respiration rates were comparable in ventricular samples of heart failure patients obtained during open heart surgery by standard tissue preparation or ex vivo endomyocardial biopsy (r = 0.9988, p < 0.0001, n = 8), and the mitochondrial oxidative capacity in samples from these patients remained stable for 8 h when stored in either of two common preservation buffers. The oxidative capacity was 44% lower in heart failure than in transplant recipients (67 ± 3 vs. 97 ± 5 pmol/[s mg], p < 0.0001) and correlated positively with heart function (r = 0.49, p < 0.01). High-resolution respirometry of ventricular tissue is feasible in transcatheter biopsies, facilitating clinical studies on myocardial mitochondrial function in patients not undergoing heart surgery.
format Online
Article
Text
id pubmed-6376010
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63760102019-02-25 High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure Scheiber, Daniel Jelenik, Tomas Zweck, Elric Horn, Patrick Schultheiss, Heinz-Peter Lassner, Dirk Boeken, Udo Saeed, Diyar Kelm, Malte Roden, Michael Westenfeld, Ralf Szendroedi, Julia Exp Mol Med Article The lifetime risk of developing heart failure is approximately 20%, and survival rates remain poor. Myocardial mitochondrial function has been suggested to play a pivotal role in heart failure pathophysiology. Human studies on ex vivo mitochondrial function have mostly been limited to atrial tissue obtained during open heart surgery and have provided contradictory results. This study aimed at measuring myocardial mitochondrial function in transcatheter ventricular endomyocardial biopsies and assessing the relationship between oxidative capacity and heart function. We enrolled 40 heart failure patients undergoing ventricular assist device surgery or heart transplantation (34 males, age 57 ± 11 years, body mass index 26.6 ± 4.8 kg/m(2)) and 29 heart transplant recipients of comparable age and body mass index with normal left ventricular function undergoing surveillance biopsies (23 males, 57 ± 12 years, body mass index 26.2 ± 4.1 kg/m(2)). High-resolution respirometry was established in the myocardium to measure oxidative capacity ex vivo. The mitochondrial oxidative capacity was 90% higher in ventricular compared to atrial tissues (n = 11, p < 0.01) of explanted hearts. Respiration rates were comparable in ventricular samples of heart failure patients obtained during open heart surgery by standard tissue preparation or ex vivo endomyocardial biopsy (r = 0.9988, p < 0.0001, n = 8), and the mitochondrial oxidative capacity in samples from these patients remained stable for 8 h when stored in either of two common preservation buffers. The oxidative capacity was 44% lower in heart failure than in transplant recipients (67 ± 3 vs. 97 ± 5 pmol/[s mg], p < 0.0001) and correlated positively with heart function (r = 0.49, p < 0.01). High-resolution respirometry of ventricular tissue is feasible in transcatheter biopsies, facilitating clinical studies on myocardial mitochondrial function in patients not undergoing heart surgery. Nature Publishing Group UK 2019-02-14 /pmc/articles/PMC6376010/ /pubmed/30765687 http://dx.doi.org/10.1038/s12276-019-0214-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Scheiber, Daniel
Jelenik, Tomas
Zweck, Elric
Horn, Patrick
Schultheiss, Heinz-Peter
Lassner, Dirk
Boeken, Udo
Saeed, Diyar
Kelm, Malte
Roden, Michael
Westenfeld, Ralf
Szendroedi, Julia
High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title_full High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title_fullStr High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title_full_unstemmed High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title_short High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
title_sort high-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376010/
https://www.ncbi.nlm.nih.gov/pubmed/30765687
http://dx.doi.org/10.1038/s12276-019-0214-6
work_keys_str_mv AT scheiberdaniel highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT jeleniktomas highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT zweckelric highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT hornpatrick highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT schultheissheinzpeter highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT lassnerdirk highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT boekenudo highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT saeeddiyar highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT kelmmalte highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT rodenmichael highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT westenfeldralf highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure
AT szendroedijulia highresolutionrespirometryinhumanendomyocardialbiopsiesshowsreducedventricularoxidativecapacityrelatedtoheartfailure